【Ciie time】Wang Hao, President of Siemens Healthiders Greater China: Continue to increase investment in innovation and localization of research and development
Zhongxin Jingwei, November 5 (Wang Yuling, Lin Wansi) The Fourth China International Import Expo (hereinafter referred to as the Ciie Expo) opened in Shanghai on November 4. On November 5, Wang Hao, President of Siemens Healthcare Greater China, was interviewed by Zhongxin Jingwei and other media, and when talking about localization substitution, he frankly said that this is both an opportunity and a challenge, and Siemens Healthcare will continue to increase investment in innovation and localization research and development, and carry out business under the guidance of macro policies.
Wang Hao, President of Siemens Healthcare Greater China, courtesy of the interviewee
The "Healthy China 2030" Planning Outline proposes to strengthen the capacity building of high-end medical device innovation. For the rise of localization medical devices, Wang Hao pointed out that Siemens Healthcare has a number of production bases in China, which will solve the problems of local manufacturing in China and adapt to the Chinese market from talents, core components, supply chains and other links, and develop localized products that are more suitable for the needs of the Chinese market.
At the same time, he said that the "14th Five-Year Plan" clearly states that it is necessary to promote the in-depth integration of production, education and research, support enterprises to lead the formation of innovation consortiums, and undertake major national science and technology projects. "To achieve localization innovation, we need to promote cooperation with local Chinese start-ups, medical institutions and research institutes to do 'meaningful innovation'."
In addition, Wang Hao proposed to promote digital innovation and differentiated development, and consolidate the technical application and landing of digital innovation of Siemens Medical. He revealed that in the field of tumor treatment and cardiovascular treatment in the future, Siemens Healthcare will continue to expand hospitals, scientific research and technology centers and local start-ups, which is also the future development strategy of Siemens Healthcare.
At this Expo, Siemens Healthcare debuted in the medical equipment and medical care exhibition area and the public health prevention zone, and simultaneously launched the new ultra-high-end equipment product - Aurora pet/ct (biograph vision quadra). Aurora pet/ct is designed for clinical and translational studies and will further guide the precision treatment of cancer. (Zhongxin Jingwei app)
Zhongxin Jingwei copyright, without written authorization, any unit and individual shall not reprint, excerpt and use in other ways.
![The number one nemesis of national table tennis, missing the Paris Olympics, Li Falcon and Wang Hao, breathed a sigh of relief[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)